Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,238,536 papers from all fields of science
Search
Sign In
Create Free Account
stage D carcinoma of the prostate
Known as:
Stage D Prostate Cancer
, carcinoma of the prostate, stage D
, Cancer of the Prostate Stage D
Expand
A prostate cancer stage defined by the Jewett staging system. Stage D prostate cancer is cancer that began in the prostate and has spread to lymph…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Epithelial Cells
Epithelium
Male Reproductive System
Malignant Epithelial Cell
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Comparison of Hormonal Therapy and Chemohormonal Therapy in Patients with Newly Diagnosed Clinical Stage D Prostatic Cancer
H. Miyake
,
I. Hara
,
+4 authors
S. Kamidono
International journal of urology
1996
Corpus ID: 35282697
Background: In order to examine the usefulness of chemohormonal therapy, we conducted a multicentered randomized trial comparing…
Expand
1995
1995
Kinetic analysis of prostatic volume in patients with stage D prostatic cancer treated with LHRH analogues in relation to prognosis.
M. Kojima
,
H. Ohe
,
H. Watanabe
British Journal of Urology
1995
Corpus ID: 11213830
OBJECTIVE To evaluate the clinical usefulness of the kinetic analysis of prostatic volume in the prognosis of patients with Stage…
Expand
1992
1992
Long-term clinical study on Luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer
H. Akaza
,
M. Usami
,
K. Koiso
,
T. Kotake
,
Y. Aso
,
T. Niijima
1992
Corpus ID: 78059303
The results of long-term administration of leuprorelin acetate depot (TAP-144-SR), a sustained-release preparation of luteinising…
Expand
1992
1992
Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group.
H. Akaza
,
M. Usami
,
K. Koiso
,
T. Kotake
,
Y. Aso
,
T. Niijima
Japanese Journal of Clinical Oncology
1992
Corpus ID: 40005776
The results of long-term administration of leuprorelin acetate depot (TAP-144-SR), a sustained-release preparation of luteinising…
Expand
1988
1988
A prospective, randomized controlled study on the treatment of stage C and stage D prostatic cancer with estracyt in combination with other chemotherapeutic agents.
H. Akaza
,
K. Isurugi
,
+7 authors
A. Gunji
Japanese Journal of Clinical Oncology
1988
Corpus ID: 25060015
The present study was designed to investigate the efficacy of various combinations of chemotherapeutic agents in the treatment of…
Expand
1985
1985
Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.
P. Bonomi
,
D. Pessis
,
+6 authors
J. Harris
Seminars in Oncology
1985
Corpus ID: 33297058
The majority of patients with advanced prostatic cancer respond either to castration or estrogen therapy. In an attempt to…
Expand
1985
1985
Comparison of immunologic and enzymatic assay of prostatic acid phosphatase for follow-up and assessment of clinical status of stage D prostate cancer.
A. El-Shirbiny
,
A. Bhargava
,
S. Beckley
,
J. Fitzpatrick
,
G. P. Murphy
Journal of Surgical Oncology
1985
Corpus ID: 31323287
1982
1982
Cisplatin, cyclophosphamide, and prednisone therapy for stage D prostatic cancer.
J. Berry
,
R. MacDonald
Cancer treatment reports
1982
Corpus ID: 8655403
1980
1980
Chemotherapy of hormone-resistant stage D prostatic cancer.
Joseph D. Schmidt
Journal of Urology
1980
Corpus ID: 45794351
Highly Cited
1979
Highly Cited
1979
Long-term survival after hormonal therapy for stage D prostatic cancer.
W. Reiner
,
W. Scott
,
J. C. Eggleston
,
P. Walsh
Journal of Urology
1979
Corpus ID: 37370147
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE